Deficient activation and different expression of transforming growth factor-β isoforms in active proliferative diabetic retinopathy and neovascular eye disease
- 1 January 1999
- journal article
- research article
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 107 (01) , 21-28
- https://doi.org/10.1055/s-0029-1212068
Abstract
An increased expression and secretion of angiogenic growth factors was proposed to occur in proliferative diabetic retinopathy and other neovascularizing retinal diseases. However, a loss of anti-angiogenic factors also might promote retinal neovascularization. Therefore we investigated the active and latent vitreous levels of the subtypes of the endothelial anti-mitogen transforming growth factor-beta in vitreous of 58 patients. Four groups of patients were compared: Controls without retinal hypoxia, patients with quiescent and active proliferative diabetic retinopathy (PDR), and patients with severe retinal hypoxia resulting in rubeosis iridis. Whereas the amount of total TGF-β in the four groups did not differ significantly, latent TGF-β isoform expression showed complex alterations in ocular vitreous. Levels of active TGF-β of patients with active PDR (79.5 ± 28 pg/ml; n = 8) were decreased to 20% of the control levels (378 ± 55 pg/ml; n = 12; p = 0.0005) and 25 % of the mean concentration in quiescent PDR (346 ± 64 pg/ml; n = 9; p = 0.0021). Levels in rubeosis (52 ± 10 pg/ml; n = 10) did not differ significantly from those found in active PDR but were decreased to 15% of those in patients with quiescent PDR (p = 0.0004). Furthermore a highly significant inverse correlation between active TGF-β and alpha2-antiplasmin, a liver produced inhibitor of the activation of TGF-β by plasmin was noted (r = -0.59; n = 28; p = 0.001). We conclude that deficient activation of TGF-β occurs in active proliferative diabetic retinopathy and in hypoxic angiogenesis most likely as a consequence of a blood retina barrier breakdown and influx of alpha2-antiplasmin from serum. The disinhibition of endothelial cell proliferation may be a central component in the process of neovascularization.Keywords
This publication has 0 references indexed in Scilit: